Skip to content
healthcare.dev

XeroBurn Burn Gel

NDC 67777-129, Lidocaine Hydrochloride, gel, from Dynarex Corporation.

Product NDC
67777-129
Status
Listed
Labeler
Dynarex Corporation
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67777-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE2 g/100g

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
67777-129-02677770129021728 PACKET in 1 CASE (67777-129-02) / 3.5 g in 1 PACKET
67777-129-0967777012909600 BOX in 1 CASE (67777-129-09) / 25 PACKET in 1 BOX (67777-129-00) / 3.5 g in 1 PACKET
67777-129-1067777012910600 BOX in 1 CASE (67777-129-10) / 6 PACKET in 1 BOX (67777-129-01) / 3.5 g in 1 PACKET
67777-129-116777701291124 BOTTLE in 1 CASE (67777-129-11) / 113 g in 1 BOTTLE (67777-129-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 67777-129 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67777-129 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67777-129. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.